Skip to main content
BioInfra Life Science Inc. logo

BioInfra Life Science Inc. — Investor Relations & Filings

Ticker · 266470 ISIN · KR7266470004 KO Professional, scientific and technical activities
Open in API
Filings indexed 121 across all filing types
Latest filing 2024-11-26 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 266470

About BioInfra Life Science Inc.

http://bioinfra.co.kr/?lang=en

BioInfra Life Science Inc. is a biotechnology company focused on cancer prevention, early detection, and treatment. The company's core technology is a multi-biomarker blood test, an in-vitro diagnostic solution designed for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This test analyzes cancer risk from a small blood sample. In addition to its diagnostic platform, the company develops cancer gene treatments and technologies to monitor the potential for metastasis and recurrence, aiming to provide innovative solutions in the healthcare field.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a capital increase (유상증자결정) and a subsequent correction (정정신고) filed with the Korean financial authorities. It details the issuance of new shares, the purpose of the capital raise, and specifically addresses a regulatory compliance issue regarding the Capital Markets Act. Since this document is a formal regulatory filing detailing capital structure changes and regulatory disclosures, it falls under the 'Share Issue/Capital Change' category.
2024-11-26 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory filing regarding the acquisition of shares in another company (Foodnamoo Co., Ltd.) by Bioinfra Life Science. It details the acquisition amount, purpose, and financial status of the target company. This type of corporate disclosure regarding M&A or strategic investment activity is classified as M&A Activity (TAR) within the provided schema.
2024-11-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Bioinfra Life Science, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It outlines the number of new shares, the purpose of the capital raise (operating funds), the third-party allocation method, and the board's resolution details. This falls under the category of announcements regarding new share issues and capital structure changes.
2024-11-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent in the US) used to disclose share ownership changes by insiders or major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS) as it reports personal share transactions and ownership status by a major shareholder/executive.
2024-10-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Lee Jeong-hoo) in BioInfra Life Science due to a third-party capital increase. This falls under the category of Major Shareholding Notification (MRQ).
2024-10-22 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2024-10-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.